1
|
Endesfelder D, Kulka U, Bucher M, Giesen U, Garty G, Beinke C, Port M, Gruel G, Gregoire E, Terzoudi G, Triantopoulou S, Ainsbury EA, Moquet J, Sun M, Prieto MJ, Moreno Domene M, Barquinero JF, Pujol-Canadell M, Vral A, Baeyens A, Wojcik A, Oestreicher U. International Comparison Exercise for Biological Dosimetry after Exposures with Neutrons Performed at Two Irradiation Facilities as Part of the BALANCE Project. Cytogenet Genome Res 2023; 163:163-177. [PMID: 37071978 PMCID: PMC10641373 DOI: 10.1159/000530728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Accepted: 04/10/2023] [Indexed: 04/20/2023] Open
Abstract
In the case of a radiological or nuclear event, biological dosimetry can be an important tool to support clinical decision-making. During a nuclear event, individuals might be exposed to a mixed field of neutrons and photons. The composition of the field and the neutron energy spectrum influence the degree of damage to the chromosomes. During the transatlantic BALANCE project, an exposure similar to a Hiroshima-like device at a distance of 1.5 km from the epicenter was simulated, and biological dosimetry based on dicentric chromosomes was performed to evaluate the participants ability to discover unknown doses and to test the influence of differences in neutron spectra. In a first step, calibration curves were established by irradiating blood samples with 5 doses in the range of 0-4 Gy at two different facilities in Germany (Physikalisch-Technische Bundesanstalt [PTB]) and the USA (the Columbia IND Neutron Facility [CINF]). The samples were sent to eight participating laboratories from the RENEB network and dicentric chromosomes were scored by each participant. Next, blood samples were irradiated with 4 blind doses in each of the two facilities and sent to the participants to provide dose estimates based on the established calibration curves. Manual and semiautomatic scoring of dicentric chromosomes were evaluated for their applicability to neutron exposures. Moreover, the biological effectiveness of the neutrons from the two irradiation facilities was compared. The calibration curves from samples irradiated at CINF showed a 1.4 times higher biological effectiveness compared to samples irradiated at PTB. For manual scoring of dicentric chromosomes, the doses of the test samples were mostly successfully resolved based on the calibration curves established during the project. For semiautomatic scoring, the dose estimation for the test samples was less successful. Doses >2 Gy in the calibration curves revealed nonlinear associations between dose and dispersion index of the dicentric counts, especially for manual scoring. The differences in the biological effectiveness between the irradiation facilities suggested that the neutron energy spectrum can have a strong impact on the dicentric counts.
Collapse
Affiliation(s)
- David Endesfelder
- Department of Effects and Risks of Ionising and Non-Ionising Radiation, Federal Office for Radiation Protection (BfS), Oberschleißheim, Germany,
| | - Ulrike Kulka
- Department of Effects and Risks of Ionising and Non-Ionising Radiation, Federal Office for Radiation Protection (BfS), Oberschleißheim, Germany
| | - Martin Bucher
- Department of Effects and Risks of Ionising and Non-Ionising Radiation, Federal Office for Radiation Protection (BfS), Oberschleißheim, Germany
| | - Ulrich Giesen
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
| | - Guy Garty
- Radiological Research Accelerator Facility (RARAF), Columbia University, Irvington, New York, USA
| | | | - Matthias Port
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - Gaetan Gruel
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-Santé, SERAMED, LRAcc, Fontenay-aux-Roses, France
| | - Eric Gregoire
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-Santé, SERAMED, LRAcc, Fontenay-aux-Roses, France
| | - Georgia Terzoudi
- Health Physics, Radiobiology & Cytogenetics Laboratory, National Centre for Scientific Research "Demokritos,", Athens, Greece
| | - Sotiria Triantopoulou
- Health Physics, Radiobiology & Cytogenetics Laboratory, National Centre for Scientific Research "Demokritos,", Athens, Greece
| | - Elizabeth A Ainsbury
- Radiation, Chemicals and Environmental Hazards Directorate, UK Health Security Agency, Chilton, Oxfordshire, UK
| | - Jayne Moquet
- Radiation, Chemicals and Environmental Hazards Directorate, UK Health Security Agency, Chilton, Oxfordshire, UK
| | - Mingzhu Sun
- Radiation, Chemicals and Environmental Hazards Directorate, UK Health Security Agency, Chilton, Oxfordshire, UK
| | - María Jesús Prieto
- Centro de Oncología Radioterápica, Laboratorio de Dosimetría Biológica, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Mercedes Moreno Domene
- Centro de Oncología Radioterápica, Laboratorio de Dosimetría Biológica, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Joan-Francesc Barquinero
- Departament de Biologia Animal, Unitat d'Antropologia Biològica, Universitat Autònoma de Barcelona, Bellaterra, Spain
| | - Monica Pujol-Canadell
- Departament de Biologia Animal, Unitat d'Antropologia Biològica, Universitat Autònoma de Barcelona, Bellaterra, Spain
| | - Anne Vral
- Faculty of Medicine and Health Sciences, Department of Human Structure and Repair, Radiobiology Research Unit, Ghent University, Gent, Belgium
| | - Ans Baeyens
- Faculty of Medicine and Health Sciences, Department of Human Structure and Repair, Radiobiology Research Unit, Ghent University, Gent, Belgium
| | - Andrzej Wojcik
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
- Institute of Biology, Jan Kochanowski University, Kielce, Poland
| | - Ursula Oestreicher
- Department of Effects and Risks of Ionising and Non-Ionising Radiation, Federal Office for Radiation Protection (BfS), Oberschleißheim, Germany
| |
Collapse
|
2
|
Bolduc DL, Blakely WF, H Olsen C, Agay D, Mestries JC, Drouet M, Hérodin F. BABOON RADIATION QUALITY (MIXED-FIELD NEUTRON AND GAMMA, GAMMA ALONE) DOSE-RESPONSE MODEL SYSTEMS: ASSESSMENT OF H-ARS SEVERITY USING HAEMATOLOGIC BIOMARKERS. RADIATION PROTECTION DOSIMETRY 2019; 186:15-23. [PMID: 31330012 DOI: 10.1093/rpd/ncz048] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/31/2018] [Revised: 02/24/2019] [Indexed: 06/10/2023]
Abstract
Results from archived (1986 and 1996) experiments were used to establish a baboon radiation-quality dose-response database with haematology biomarker time-course data following exposure to mixed-fields (i.e. neutron to gamma ratio: 5.5; dose: 0-8 Gy) and 60Co gamma-ray exposures (0-15 Gy). Time-course (i.e. 0-40 d) haematology changes for relevant blood-cell types for both mixed-field (neutron to gamma ratio = 5.5) and gamma ray alone were compared and models developed that showed significant differences using the maximum likehood ratio test. A consensus METREPOL-like haematology ARS (H-ARS) severity scoring system for baboons was established using these results. The data for mixed-field and the gamma only cohorts appeared similar, and so the cohorts were pooled into a single consensus H-ARS severity scoring system. These findings provide proof-of-concept for the use of a METREPOL H-ARS severity scoring system following mixed-field and gamma exposures.
Collapse
Affiliation(s)
- David L Bolduc
- Uniformed Services University of the Health Sciences, Armed Forces Radiobiology Research Institute, Scientific Research Department, Bethesda, MD, USA
| | - William F Blakely
- Uniformed Services University of the Health Sciences, Armed Forces Radiobiology Research Institute, Scientific Research Department, Bethesda, MD, USA
| | - Cara H Olsen
- Uniformed Services University of the Health Sciences, Preventive Medicine and Biostatistics Department, Bethesda, MD, USA
| | - Diane Agay
- Effets Biologiques des Rayonnements Département, Institut de Recherche Biomédicale des Armées, Brétigny sur Orge, France
| | - Jean-Claude Mestries
- Effets Biologiques des Rayonnements Département, Institut de Recherche Biomédicale des Armées, Brétigny sur Orge, France
| | - Michel Drouet
- Effets Biologiques des Rayonnements Département, Institut de Recherche Biomédicale des Armées, Brétigny sur Orge, France
| | - Francis Hérodin
- Effets Biologiques des Rayonnements Département, Institut de Recherche Biomédicale des Armées, Brétigny sur Orge, France
| |
Collapse
|
3
|
Trott KR. Special radiobiological features of second cancer risk after particle radiotherapy. Phys Med 2017; 42:221-227. [PMID: 29103987 DOI: 10.1016/j.ejmp.2017.05.002] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2016] [Revised: 04/18/2017] [Accepted: 05/01/2017] [Indexed: 11/24/2022] Open
Abstract
In absolute terms: second cancer risks from radiotherapy of first cancers in adults are small compared to the benefits from radiotherapy but this is not so for radiotherapy of childhood cancers. Moreover, the radiation dose dependence of cancer induction differs between organs and tissues. The organ-specific dose dependence of second cancer risks may indicate the existence of different radiobiological mechanisms. As an inevitable consequence of the age dependence of organ sensitivity to second cancer induction, the organ/tissue weighting factors which have been proposed by ICRP for calculating effective dose (the dose unit Sv) and for risk estimation in the general population should not be used in medical radiation exposures. In adult cancer radiotherapy, the most common unwanted effect is local tumour recurrence whereas both, severe late normal tissue damage and radiation-induced second cancers are rare, around 1% of locally controlled cancer patients. In childhood cancers, local failures are rare (<10% in some cancers) yet second cancers are more common than uncontrolled primaries. The main reason for considering particle radiotherapy for childhood cancers is the possibility to exploit their physical characteristics to reduce the radiation exposure to organs and tissues close to and distant from the primary cancer which is to be targeted. However, the relative biological effectiveness of the radiation doses within the proton beam is not a constant and the relative biological effectiveness of the neutrons is not known as far as the mechanisms of late normal tissue damage and second cancer risk are concerned. In view of the highly charged discussions of the potential risks of treatment-induced seecond cancers from the neutron contamination of exposure doses in out-of-PTV critical organs a comprehensive European project called ANDANTE was performed which integrated the disciplines of radiation physics, molecular biology, systems biology modelling and epidemiology in order to investigate the RBE of induction of cancer from exposure to neutrons compared to photons. Since out-of-field "effective" neutron doses from proton therapy are smaller than the photon stray doses whichever reasonable RBE is chosen for comparison, and since the absolute risk of radiation-induced second cancer rates are in the order of 1% in the cohorts of adult patients who have been treated in the past with methods which caused relatively high out-of-field doses to large body volumes, it is highly unlikely that such patients treated in future with highly conformal particle therapy are at a higher radiation-induced second cancer risk than those patients treated with photons and described before. Still, the potential risks of second cancers from scattered proton radiotherapy for childhood cancers may cause concern. Yet, the overall risk of undesired consequences of radiation exposure of children which are more complex and manifold than in adult patients (including developmental, neurocognitive, hormonal and growth impairment effects) are likely to be very much reduced by the better focussing of the radiation dose in the target offered by particle radioherapy. This benefit may far outweigh the still hypothetical second cancer risk from particle radiotherapy in pediatric radiotherapy.
Collapse
|
4
|
Schmid TE, Greubel C, Dollinger G, Schmid E. The influence of reference radiation photon energy on high-LET RBE: comparison of human peripheral lymphocytes and human-hamster hybrid A L cells. RADIATION AND ENVIRONMENTAL BIOPHYSICS 2017; 56:79-87. [PMID: 28144741 DOI: 10.1007/s00411-016-0680-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Accepted: 12/27/2016] [Indexed: 06/06/2023]
Abstract
The relative biological effectiveness (RBE) based on the induction of dicentrics in any cell type is principally an important information for the increasing application of high-LET radiation in cancer therapy. Since the standard system of human lymphocytes for measuring dicentrics are not compatible with our microbeam irradiation setup where attaching cells are essential, we used human-hamster hybrid AL cells which do attach on foils and fulfil the special experimental requirement for microbeam irradiations. In this work, the dose-response of AL cells to photons of different energy, 70 and 200 kV X-rays and 60Co γ-rays, is characterized and compared to human lymphocytes. The total number of induced dicentrics in AL cells is approximately one order of magnitude smaller. Despite the smaller α and β parameters of the measured linear-quadratic dose-response relationship, the α/β-ratio versus photon energy dependence is identical within the accuracy of measurement for AL cells and human lymphocytes. Thus, the influence of the reference radiation used for RBE determination is the same. For therapy relevant doses of 2 Gy (60Co equivalent), the difference in RBE is around 20% only. These findings indicate that the biological effectiveness in AL cells can give important information for human cells, especially for studies where attaching cells are essential.
Collapse
Affiliation(s)
- T E Schmid
- Institute of Innovative Radiotherapy, Helmholtz Zentrum München, Munich, Germany.
- Klinikum rechts der Isar, Department of Radiation Oncology, Technische Universität München, 81675, Munich, Germany.
| | - C Greubel
- Institute for Applied Physics and Metrology, Universität der Bundeswehr München, 85577, Neubiberg, Germany
| | - G Dollinger
- Institute for Applied Physics and Metrology, Universität der Bundeswehr München, 85577, Neubiberg, Germany
| | - E Schmid
- BioMedizinisches Centrum, Lehrstuhl Zellbiologie, Anatomie III, University of Munich, 80336, Munich, Germany
| |
Collapse
|
5
|
Sasaki MS, Endo S, Hoshi M, Nomura T. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review. JOURNAL OF RADIATION RESEARCH 2016; 57:583-595. [PMID: 27614201 PMCID: PMC5137296 DOI: 10.1093/jrr/rrw079] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/08/2016] [Revised: 05/09/2016] [Accepted: 06/12/2016] [Indexed: 06/06/2023]
Abstract
The calculated risk of cancer in humans due to radiation exposure is based primarily on long-term follow-up studies, e.g. the life-span study (LSS) on atomic bomb (A-bomb) survivors in Hiroshima and Nagasaki. Since A-bomb radiation consists of a mixture of γ-rays and neutrons, it is essential that the relative biological effectiveness (RBE) of neutrons is adequately evaluated if a study is to serve as a reference for cancer risk. However, the relatively small neutron component hampered the direct estimation of RBE in LSS data. To circumvent this problem, several strategies have been attempted, including dose-independent constant RBE, dose-dependent variable RBE, and dependence on the degrees of dominance of intermingled γ-rays. By surveying the available literature, we tested the chromosomal RBE of neutrons as the biological endpoint for its equivalence to the microdosimetric quantities obtained using a tissue-equivalent proportional counter (TEPC) in various neutron fields. The radiation weighting factor, or quality factor, Qn, of neutrons as expressed in terms of the energy dependence of the maximum RBE, RBEm, was consistent with that predicted by the TEPC data, indicating that the chromosomally measured RBE was independent of the magnitude of coexisting γ-rays. The obtained neutron RBE, which varied with neutron dose, was confirmed to be the most adequate RBE system in terms of agreement with the cancer incidence in A-bomb survivors, using chromosome aberrations as surrogate markers. With this RBE system, the cancer risk in A-bomb survivors as expressed in unit dose of reference radiation is equally compatible with Hiroshima and Nagasaki cities, and may be potentially applicable in other cases of human radiation exposure.
Collapse
Affiliation(s)
- Masao S Sasaki
- Kyoto University and National Institute of Biomedical Innovation, Health and Nutrition, 17-12 Shironosato, Nagaokakyo-shi, Kyoto 617-0835, Japan
| | - Satoru Endo
- Quantum Energy Application, Graduate School of Engineering, Hiroshima University, 1-4-1 Kagamiyama, Higashi-hiroshima, Hiroshima 739-8527, Japan
| | - Masaharu Hoshi
- Institute for Peace Science, Hiroshima University, 1-1-89 Higashisenda, Naka-ku, Hiroshima 730-0053, Japan
| | - Taisei Nomura
- National Institute of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito-Asagi, Ibaraki-shi, Osaka 567-0086, Japan
| |
Collapse
|
6
|
Isaeva EV, Beketov EE, Koryakin SN, Ulyanenko SE, Lychagin AA. A comparative study of the biological effectiveness of 14-MeV neutron pulse and continuous radiation using mouse melanoma B-16 cells. RADIATION PROTECTION DOSIMETRY 2014; 161:478-482. [PMID: 24101654 DOI: 10.1093/rpd/nct247] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The study was carried out using compact neutron generators with a sealed tube operating in pulsed (neutron generator ING-031) and continuous (NG-14) modes. Neutron radiation was formed due to reaction T(d,n)(4)He. The average flow of 14-MeV neutrons was 6.6×10(9) ns(-1) for ING-031 and 1.2-1.6×10(10) n s(-1) for NG-14. Duration of an impulse was ∼1 ms and pulse frequency of 50 Hz. The gamma rays of (60)Со source with an average energy of 1.25 MeV were standard radiation. Biological efficacy was estimated using the clonogenic activity of mice melanoma B-16 cells. Comparison of biological effects of neutron irradiation in pulse and continuous modes showed no significant difference between them. RBE values of pulse (ING-031) and continuous (NG-14) neutron radiation were equal-in the range of 2.4-2.6. According to the clonogenic activity of melanoma B-16 cells no dose rate effect was observed within the studied range of neutrons doses and dose rates.
Collapse
Affiliation(s)
- E V Isaeva
- Medical Radiological Research Center, 4 Korolev St., Obninsk 249036, Russia
| | - E E Beketov
- Medical Radiological Research Center, 4 Korolev St., Obninsk 249036, Russia
| | - S N Koryakin
- Medical Radiological Research Center, 4 Korolev St., Obninsk 249036, Russia
| | - S E Ulyanenko
- Medical Radiological Research Center, 4 Korolev St., Obninsk 249036, Russia
| | - A A Lychagin
- Medical Radiological Research Center, 4 Korolev St., Obninsk 249036, Russia
| |
Collapse
|
7
|
Ottolenghi A, Smyth V, Trott K. Assessment of cancer risk from neutron exposure – The ANDANTE project. RADIAT MEAS 2013. [DOI: 10.1016/j.radmeas.2012.10.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
8
|
Schmid E, Wagner FM, Canella L, Romm H, Schmid TE. RBE of thermal neutrons for induction of chromosome aberrations in human lymphocytes. RADIATION AND ENVIRONMENTAL BIOPHYSICS 2013; 52:113-121. [PMID: 23263356 DOI: 10.1007/s00411-012-0449-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/24/2012] [Accepted: 12/10/2012] [Indexed: 06/01/2023]
Abstract
The induction of chromosome aberrations in human lymphocytes irradiated in vitro with slow neutrons was examined to assess the maximum low-dose RBE (RBE(M)) relative to (60)Co γ-rays. For the blood irradiations, cold neutron beam available at the prompt gamma activation analysis facility at the Munich research reactor FRM II was used. The given flux of cold neutrons can be converted into a thermally equivalent one. Since blood was taken from the same donor whose blood had been used for previous irradiation experiments using widely varying neutron energies, the greatest possible accuracy was available for such an estimation of the RBE(M) avoiding the inter-individual variations or differences in methodology usually associated with inter-laboratory comparisons. The magnitude of the coefficient α of the linear dose-response relationship (α = 0.400 ± 0.018 Gy(-1)) and the derived RBE(M) of 36.4 ± 13.3 obtained for the production of dicentrics by thermal neutrons confirm our earlier observations of a strong decrease in α and RBE(M) with decreasing neutron energy lower than 0.385 MeV (RBE(M) = 94.4 ± 38.9). The magnitude of the presently estimated RBE(M) of thermal neutrons is-with some restrictions-not significantly different to previously reported RBE(M) values of two laboratories.
Collapse
Affiliation(s)
- E Schmid
- Department for Anatomy and Cell Biology, Ludwig-Maximilians-University of Munich, 80336 Munich, Germany.
| | | | | | | | | |
Collapse
|